Home/Median Technologies/Fredrik Ljungström
FL

Fredrik Ljungström

Major Shareholder/Investor

Median Technologies

Therapeutic Areas

Median Technologies Pipeline

DrugIndicationPhase
eyonis® LCSLung Cancer ScreeningCommercial
eyonis® LiverLiver Disease/CancerDevelopment
Imaging Lab ServicesOncology Clinical TrialsCommercial
iCRO (Imaging Core Lab)Oncology Clinical TrialsCommercial